Feasibility Of continuous non-invasive blood pressure measurement in cardiac Resynchronization ThErapy

Feasibility Of continuous non-invasive blood pressure measurement in cardiac Resynchronization ThErapy - FORTE-study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

NL-OMON

Registry ID

NL-OMON36535

Enrollment

Registered

2010-04-19

Start date

2011-11-30

Completion date

Unknown

Last updated

2024-05-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

failure of pumpfunction of the heart Heart failure

Interventions

None listed

Eligibility

Age

18 Years to 99 Years

Inclusion criteria

Inclusion criteria: 1) End stage heart failure with NYHA class II, III or IV despite optimal medical treatment 2) QRS duration > 120msec for patients in NYHA class III or IV, QRS duration > 150msec for patients in NYHA class II 3) Left ventricular ejection fraction

Exclusion criteria

Exclusion criteria: 1) Age

Design outcomes

Primary

Measure	Time frame
Difference of 3.5% in left ventricular ejection fraction between both strategies measured by 3-D echocardiography.	—

Secondary

Measure	Time frame
Changes in NYHA classification, NT-pro-BNP, 6-MWT, and QOL score assessed by the Minnesota Living with Heart Failure questionnaire, LVEDD, LVESD, LVEDV and LVESV, MR, incidence of ventriculartachycardia or fibrillation (VT, VF), ICD delivered antitachycardia pacing (ATP) and shocks, days of hospitalization for or associated with worsening HF and mortality of any cause.	—

Countries

Netherlands

Outcome results